RxDoctor Payments Data

Allen Mitchell, MD

Otolaryngology · Portsmouth, VANPI 1740393370

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,572 of the $3,416 with a category attached, or 75.3%. Inspire Medical Systems, Inc. accounts for 85.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,742 and has fallen 78.5% since, to $375 in 2025.

$3,416in general payments, 2019–2025

Across 53 payments — averaging $64.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Comsort, Inc$150
  • Regeneron Healthcare Solutions, Inc.$94
  • Intersect ENT, Inc.$73
  • Sanofi$58
  • Optinose US, Inc.$43
  • plus $78 from 3 others

What the payments were for

  • Consulting fees$1504%
  • Travel & lodging$69420%
  • Food & beverage$2,57275%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,416 in reported general payments places this provider in the 75th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia →

Medicare billing

Part B allowed, 2024
$25,326
Medicare patients
151
Services billed
247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate51$655
Ipratropium Bromide41$579
Flunisolide15$351
Pantoprazole Sodium28$266
Famotidine47$226
Omeprazole24$212
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$82

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Portsmouth

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →